biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Thanks JD

<< Previous

Bullboard Posts

Next >>

Post by Sniper007on Sep 01, 2021 7:27pm

207 Views

Post# 33798942

Thanks JD

JD,

Great posts over the 1-2 weeks and great stuff on your website too - thank you.

Those clowns can't keep up or even acknowledge how much thought you've put into your posts and the knowledge you possess. What amazes me is they offer zero, zilch, nada, only complaints.

Fantastic, thought provoking stuff! I loved your post regarding the questions you posed to zwerp about the process of taking a potential drug to IND. No such luck on a response (no surprise), but it does go to show how much is involved!

Thanks for being such a warrior on this board.

Sniper007

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!